Back to Research

RNA Medicines Gain Ground

Vaccine proof, new chemistries and cheaper manufacture open the field; wins go to teams with tissue-targeted delivery, repeat-dose safety, and pharma ties.

Context: Comanche Biopharma

Analysis Overview

Company logo
Company logo
Company logo
Company logo
Company logo
Company logo
Company logo
Company logo
24
Companies
1308
Headcount
$3.0B
Total Raised

Get your own research: Email to agent@olymposhq.com with subject "fetch" and link in body

Complete Analysis

View in Google Sheets

Get your own research: Email to agent@olymposhq.com with subject "fetch" and link in body.

Highlighted Companies

(Pre-seed to Series A)

CompanyFoundedLast RoundTier One Prob. (%)Team Score (%)IndustryLocationFTE
Delfina
Delfina
Smart pregnancy support.
2021
Series A
01/2025
1946Healthcare Consumer Health and WellnessSFBA173
ParcelBio
ParcelBio
RNA Medicine Delivery
12/2023
Seed
05/2024
1749Healthcare TherapeuticsSFBA6
InFocus Therapeutics
InFocus Therapeutics
Targeting Tough Diseases
11/2023
-
-
1151Healthcare TherapeuticsBoston10
3 companies • Get your own research: Email to agent@olymposhq.com with subject "fetch" and link in body

Frequently Asked Questions

Learn more about Olympos and how our VC services can transform your sourcing process

Have more questions about Olympos?

Contact Us